By MATTHEW DIXON
Professors at MU may soon be saving the lives of everyone’s favorite household pet.
Kim Selting, assistant teaching professor of oncology at the MU College of Veterinary Medicine, is the principal investigator in a study that examines the efficacy of Attaxol™ in dogs with naturally occurring cancer.
“Cancer is one of the most common causes of death in dogs,” Selting said in an MU news release. “This study is important because most chemotherapy drugs available to people can be used in dogs except for the highly successful taxanes that can keep cancer from proliferating throughout the body.”
Professors at MU’s College of Veterinary Medicine will conduct part of the study focusing on the cancer response in the dogs involved in the study.
Enrollment of dogs in the study will start this month and it is estimated that the study itself will take about two years to complete